Voest EE - Search Results

1

Regulation of E2F1 by the von Hippel-Lindau tumour suppressor protein predicts survival in renal cell cancer patients.

Mans DA, Vermaat JS, Weijts BG, van Rooijen E, van Reeuwijk J, Boldt K, Daenen LG, van der Groep P, Rowland BD, Jans JJ, Roepman R, Voest EE, van Diest PJ, Verhaar MC, de Bruin A, Giles RH. Mans DA, et al. Among authors: voest ee. J Pathol. 2013 Sep;231(1):117-29. doi: 10.1002/path.4219. J Pathol. 2013. PMID: 23744542

2

Expression pattern of the von Hippel-Lindau protein in human tissues.

Los M, Jansen GH, Kaelin WG, Lips CJ, Blijham GH, Voest EE. Los M, et al. Among authors: voest ee. Lab Invest. 1996 Aug;75(2):231-8. Lab Invest. 1996. PMID: 8765323

3

Elevated ocular levels of vascular endothelial growth factor in patients with von Hippel-Lindau disease.

Los M, Aarsman CJ, Terpstra L, Wittebol-Post D, Lips CJ, Blijham GH, Voest EE. Los M, et al. Among authors: voest ee. Ann Oncol. 1997 Oct;8(10):1015-22. doi: 10.1023/a:1008213320642. Ann Oncol. 1997. PMID: 9402176 Free article. Clinical Trial.

4

Regulation of the urokinase-type plasminogen activator system by the von Hippel-Lindau tumor suppressor gene.

Los M, Zeamari S, Foekens JA, Gebbink MF, Voest EE. Los M, et al. Among authors: voest ee. Cancer Res. 1999 Sep 1;59(17):4440-5. Cancer Res. 1999. PMID: 10485495

5

[Von Hippel-Lindau disease].

Los M, Links TP, Lenders JW, Voest EE. Los M, et al. Among authors: voest ee. Ned Tijdschr Geneeskd. 2000 Mar 11;144(11):497-501. Ned Tijdschr Geneeskd. 2000. PMID: 10735133 Review. Dutch.

6

Mutational analysis of endothelial cells derived from von Hippel-Lindau-related renal cancer.

Los M, Kerckhaert OA, Zewald R, van Amstel HK, Voest EE. Los M, et al. Among authors: voest ee. J Natl Cancer Inst. 2000 Oct 18;92(20):1688-9. doi: 10.1093/jnci/92.20.1688. J Natl Cancer Inst. 2000. PMID: 11036115 No abstract available.

7

Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients.

Beerepoot LV, Mehra N, Vermaat JS, Zonnenberg BA, Gebbink MF, Voest EE. Beerepoot LV, et al. Among authors: voest ee. Ann Oncol. 2004 Jan;15(1):139-45. doi: 10.1093/annonc/mdh017. Ann Oncol. 2004. PMID: 14679134 Free article.

8

Are tumours angiogenesis-dependent?

Verheul HM, Voest EE, Schlingemann RO. Verheul HM, et al. Among authors: voest ee. J Pathol. 2004 Jan;202(1):5-13. doi: 10.1002/path.1473. J Pathol. 2004. PMID: 14694516 Review.

9

Fibronectin is a hypoxia-independent target of the tumor suppressor VHL.

Bluyssen HA, Lolkema MP, van Beest M, Boone M, Snijckers CM, Los M, Gebbink MF, Braam B, Holstege FC, Giles RH, Voest EE. Bluyssen HA, et al. Among authors: voest ee. FEBS Lett. 2004 Jan 2;556(1-3):137-42. doi: 10.1016/s0014-5793(03)01392-9. FEBS Lett. 2004. PMID: 14706840 Free article.

10

The von Hippel-Lindau tumor suppressor protein influences microtubule dynamics at the cell periphery.

Lolkema MP, Mehra N, Jorna AS, van Beest M, Giles RH, Voest EE. Lolkema MP, et al. Among authors: voest ee. Exp Cell Res. 2004 Dec 10;301(2):139-46. doi: 10.1016/j.yexcr.2004.07.016. Exp Cell Res. 2004. PMID: 15530850

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

363 results

Search Page

Filters